Related Experiment Video
Updated: Feb 2, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
Effectiveness of high-dose glucocorticoids on hemolysis, elevating liver enzymes, and reducing platelets syndrome
Suya Kang1, Liping Zhou1, Xiaoyan Wang1
1Department of Obstetrics, Suzhou Affiliated Hospital of Nanjing Medical University, Suzhou Municipal Hospital, China.
Insights
High-dose glucocorticoids did not significantly improve outcomes for patients with hemolysis, elevating liver enzymes, and reducing platelets (HELLP) syndrome. The treatment showed no substantial benefits in maternal or fetal prognoses or laboratory markers.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Critical Care Medicine
Background:
- Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome is a severe obstetric complication.
- Effective therapeutic strategies for HELLP syndrome remain an area of active research.
- Glucocorticoids are sometimes used, but their efficacy requires further investigation.
Purpose of the Study:
- To evaluate the effectiveness of high-dose glucocorticoid therapy in patients diagnosed with HELLP syndrome.
- To assess the impact of glucocorticoids on maternal and fetal outcomes.
- To analyze changes in key laboratory indices associated with HELLP syndrome.
Main Methods:
- A cohort of 151 patients with HELLP syndrome was analyzed.
- Patients were divided into treatment (high-dose glucocorticoids) and control groups.
- Subgroup analysis was performed based on disease severity using the American Mississippi Diagnostic Criteria.
Main Results:
- No significant differences were observed in maternal complications, including hemorrhage, ICU admission, or mortality, between groups.
- Fetal outcomes, such as perinatal mortality and adverse event rates, did not differ significantly.
- While one subgroup showed a higher preterm delivery rate in the treatment group, overall laboratory markers and key clinical outcomes showed no improvement.
Conclusions:
- High-dose glucocorticoids do not appear to significantly improve maternal and fetal prognoses in HELLP syndrome.
- The study suggests limited clinical benefit of this treatment regimen for HELLP syndrome based on current evidence.
- Further research may be needed to explore alternative or adjunctive therapies for HELLP syndrome.
Objective:
To investigate the effectiveness of high-dose glucocorticoids on hemolysis, elevating liver enzymes, and reducing platelets (HELLP) syndrome.
Methods:
A total of 151 patients with HELLP syndrome were analyzed and divided into two groups. Six subgroups of treatment and control groups were divided into three grades in accordance with the American Mississippi Diagnostic Criteria.
Results:
There were no differences in general characteristics of the patients, primipara rate, minimum platelet recovery time, postpartum hemorrhage volume, postpartum hemorrhage rate, cumulative average of maternal damage, intensive care unit admission rate, perinatal mortality rate, and overall incidence rate of adverse outcomes in fetuses among the groups. The primipara rate in the control group of the third grade was significantly higher than that in the treatment group of the third grade. The treatment group of the second grade (88.7%) had a significantly higher preterm delivery rate than that in the control group of the second grade (66.7%). There were no differences in minimum hemoglobin, and maximum lactate dehydrogenase, alanine aminotransferase, and aspartate aminotransferase levels among the groups and subgroups.
Conclusion:
High-dose glucocorticoids cannot significantly improve maternal and fetal prognoses and laboratory indices. However, our results might offer some clinical evidence for HELLP syndrome therapy.
More Related Videos
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Freezing Point Depression and Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme Kinetics
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
Elevation of Intermediate Points on Vertical Curves
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

